期刊文献+

腹腔动脉干区淋巴结清扫术在食管癌和贲门癌治疗中的价值 被引量:1

Clinical Value of Wide-excision of Celiac Trunk Lymph Node for Thoracic Esophageal Carcinoma and Cardiac Cancer
下载PDF
导出
摘要 目的:了解食管癌和贲门癌腹腔动脉干区淋巴结的转移特点及对预后的影响,探讨合理的腹腔区域淋巴结清扫范围。方法:对836例手术切除食管癌和贲门癌患者的临床资料进行分析。结果:腹腔淋巴结转移率60.3%,淋巴结转移度16.8%。肝总动脉旁、腹腔动脉旁、肝十二指肠韧带内淋巴结转移度分别为10.4%、10.1%和9.8%。患者术后3年腹腔淋巴结复发转移率为6.1%。患者术后3年生存率为55.7%,其中有腹腔淋巴结转移的患者术后3年生存率为44.6%,低于无腹腔淋巴结转移的患者(72.4%),P<0.05。结论:腹腔淋巴结转移是影响食管癌和贲门癌切除患者预后的一个主要因素,对腹腔动脉干区淋巴结的广泛清扫可以降低术后的局部复发率。 Objective: To investigate characteristics of celiac trunk lymph-node metastases of thoracic esophageal carcinoma and cardiac cancer and their influence on the prognosis, and to investigate a reasonable range for regional celiac trunk lymph-node clearance. Methods: Specimens from 836 patients treated with resection of thoracic esophageal carcinoma and cardiac cancer were retrospectively analyzed. Results: The rate of celiac lymph-node metastasis was 60.3% (502/836). Of the lymph nodes detected, 16.8% were found with metastasis. The extent of metastasis adjacent to the common hepatic artery and celiac trunk and within the hepatoduodenal ligaments was 10.8%, 10.1% and 9.8%, respectively. The overall rate of regional celiac recurrence at 3 years after surgery was 6.1%. The 3-year survival for patients with metastases in the celiac lymph nodes was 44.6%, lower than that in non-metastatic patients (72.4%) (P〈0.05). Conclusion: Celiac lymph-node metastasis is one of key factors affecting the prognosis of patients treated with resection of esophageal cancer and cardiac cancer. Extensive clearance of the celiac-trunk lymph nodes can reduce the rate of postoperative regional metastasis.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2010年第3期164-166,共3页 Chinese Journal of Clinical Oncology
关键词 食管癌 贲门癌 腹腔动脉干区 淋巴结清扫术 预后 Esophageal neoplasm Cardiac cancer Celiac trunk Lymphadenectomy Prognosis
  • 相关文献

参考文献10

  • 1Hosch SB, Stoecklein NH, Pichtmeier U, et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance[J].J Clin Oncol, 2001, 19(7): 1970-1975.
  • 2Griffiths EA, Prkchard SA, Mapstone NP, et al. Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology-an update for the surgical oncologist[J]. WorldJ Surg Oncol, 2006, 4: 82-87.
  • 3Fujita H, Sueyoshi S, Tanaka T, et al. Three-field dissection for squamous cell carcinoma in the thoracic esophagus [J]. Ann Thorac Cardiovasc Surg, 2002, 8(6): 328-335.
  • 4Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma[J].Ann Surg, 2004, 240(6): 962-972.
  • 5Altorki N, Kent M, Ferrara C, et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus [J].Ann Surg, 2002, 236(2): 177-183.
  • 6Noguchi T, Wada S, Takeno S, et al. Two-step three-field lymph node dissection is beneficial for thoracic esophageal carcinoma[J]. Dis Esophagus, 2004, 17(1): 27-31.
  • 7Altorld N, Skinner D. Should enbloc esophagectomy be the standard of care for esophageal carcinoma[J].? Ann Surg, 2001, 234(5): 581-587.
  • 8O'RiordanJM, Rowley S, MurphyJO, et al. Impact of solitary involved lymph node on outcome in localized cancer of the esophagus and esophagogastric junction[J]. J Gastrointest Surg, 2007, 11 (4) : 493-499.
  • 9Igaki H, Tachimori Y, Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection[]]. Ann Surg, 2004, 239(4): 483-490.
  • 10ChristeinJD, Hollinger EF, Millikan KW. Prognostic factors associated with resectable carcinoma of the esophagus[J]. Am Surg, 2002, 68(3): 258-262.

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部